| Univariate | Multivariate | ||
---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | |
Treatment intervala | ||||
 Group 1 | 1 (reference) |  |  |  |
 Group 2 | 0.772 (0.405–1.472) | 0.433 |  |  |
Age | ||||
 < 65 yr | 1 (reference) |  |  |  |
 ≥ 65 yr | 0.202 (0.028–1.479) | 0.115 |  |  |
CA-125 | ||||
 < 40 U/mL | 1 (reference) |  | 1 (reference) |  |
 ≥ 40 U/mL | 2.664 (1.401–5.065) | 0.003 | 1.930 (0.997–3.776) | 0.054 |
Histology | ||||
 Serous | 1 (reference) |  |  |  |
 Non-serous | 1.820 (0.900–3.682) | 0.096 |  |  |
Surgery | ||||
 Laparoscopy | 1 (reference) |  | 1 (reference) |  |
 Laparotomy | 3.060 (1.081–8.661) | 0.035 | 2.572 (0.889–7.438) | 0.081 |
ASA scoreb | ||||
 1 | 1 (reference) |  |  |  |
 2, 3 | 1.057 (0.484–2.310) | 0.889 |  |  |
Residual diseasec | ||||
 R0 | 1 (reference) |  | 1 (reference) |  |
 R1, R2 | 3.699 (1.929–7.093) | < 0.001 | 3.018 (1.486–6.130) | 0.002 |
Platinum free interval | ||||
 6-12mo | 1 (reference) |  | 1 (reference) |  |
 over 12mo | 0.462 (0.224–0.954) | 0.037 | 0.398 (0.180–0.880) | 0.023 |
Recurrence no. | ||||
 1st recur | 1 (reference) |  |  |  |
 2nd recur | 1.277 (0.451–3.619) | 0.645 |  |  |